SCHEMBL30950493

SCHEMBL30950493

C=CC(=O)Nc1cc(F)ccc1-c1nc2c(-c3ccc(CNC(=O)c4nc(C(C)(C)C)no4)c(F)c3)ccnc2[nH]1

nearest known ligand 0.56

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ BTK Q06187 20/20 0.56
▸ LCK P06239 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27459947 1.00 BTK (0.56) BTKLCK
SCHEMBL27459945 0.95 BTK (0.56) BTKLCK
SCHEMBL30950511 0.94 BTK (0.56) BTKLCK
SCHEMBL27453882 0.94 BTK (0.56) BTKLCK
SCHEMBL30950569 0.93 BTK (0.55) BTKLCK
SCHEMBL27453785 0.93 BTK (0.55) BTKLCK
SCHEMBL27453884 0.93 BTK (0.54) BTKLCK
SCHEMBL30950517 0.93 BTK (0.54) BTKLCK
SCHEMBL17645657 0.93 BTK (0.57) BTKLCK
SCHEMBL30950472 0.90 BTK (0.56) BTKLCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024129395-A1 BTK INHIBITORS GWYNANT THERAPEUTICS, INC. (US) 2024-06-20 — — WO disclosed
Send feedback